Michael D. Hall, PhD Program Manager, Congressionally Directed Medical Research Programs U.S. Army Medical Research and Development Command Dr. Michael Hall currently serves as the Program Manager for the Prostate Cancer Research Program (PCRP), within the Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Development Command at Fort Detrick, MD. As the Program Manager, Dr. Hall leads the Integrated Program Team to provide strategic oversight of the annual $110M PCRP appropriation to achieve the mission to fund research that will eliminate death and suffering from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease.Joining CDMRP in 2020, Dr. Hall managed a large portfolio of in-progress research projects in the areas of lung cancer and kidney cancer as a Science Officer. His portfolio included basic, translational, and clinical studies across the continuum of care, including a unique multi-institutional virtual academy of promising investigators in renal cell carcinoma. Prior to this role, Dr. Hall assisted multiple CDMRP Programs as a member of the contract team supporting Programmatic Review, Vision Setting, and publicity at Leidos Biomedical Research, Inc.Dr. Hall served a three-year appointment as a Research Fellow, following his Cancer Research Training Award postdoctoral fellowship in the Renal Differentiation and Neoplasia Section of the Cancer and Developmental Biology Laboratory, National Cancer Institute-Frederick. His research fellowships focused on the use of conditional genetic models to study the development of the mammalian urogenital and skeletal systems. Before earning his doctorate, he worked in the biopharmaceutical industry at Human Genome Sciences (now GlaxoSmithKline) where he participated in late phase biodistribution analyses of the FDA approved anthrax prophylactic, raxibacumab.Dr. Hall holds a Ph.D. degree in Tumor Biology from the Lombardi Comprehensive Cancer Center at Georgetown University, and dual Bachelor’s degrees in Marine and Molecular Biology from the Florida Institute of Technology. His academic awards include the Beverly McKinnelMemorial Award (International Society for Differentiation) and the Fellows Award for Research Excellence (National Institutes of Health).
Dr. Michael Hall currently serves as the Program Manager for the Prostate Cancer Research Program (PCRP), within the Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Development Command at Fort Detrick, MD. As the Program Manager, Dr. Hall leads the Integrated Program Team to provide strategic oversight of the annual $110M PCRP appropriation to achieve the mission to fund research that will eliminate death and suffering from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease.Joining CDMRP in 2020, Dr. Hall managed a large portfolio of in-progress research projects in the areas of lung cancer and kidney cancer as a Science Officer. His portfolio included basic, translational, and clinical studies across the continuum of care, including a unique multi-institutional virtual academy of promising investigators in renal cell carcinoma. Prior to this role, Dr. Hall assisted multiple CDMRP Programs as a member of the contract team supporting Programmatic Review, Vision Setting, and publicity at Leidos Biomedical Research, Inc.Dr. Hall served a three-year appointment as a Research Fellow, following his Cancer Research Training Award postdoctoral fellowship in the Renal Differentiation and Neoplasia Section of the Cancer and Developmental Biology Laboratory, National Cancer Institute-Frederick. His research fellowships focused on the use of conditional genetic models to study the development of the mammalian urogenital and skeletal systems. Before earning his doctorate, he worked in the biopharmaceutical industry at Human Genome Sciences (now GlaxoSmithKline) where he participated in late phase biodistribution analyses of the FDA approved anthrax prophylactic, raxibacumab.Dr. Hall holds a Ph.D. degree in Tumor Biology from the Lombardi Comprehensive Cancer Center at Georgetown University, and dual Bachelor’s degrees in Marine and Molecular Biology from the Florida Institute of Technology. His academic awards include the Beverly McKinnelMemorial Award (International Society for Differentiation) and the Fellows Award for Research Excellence (National Institutes of Health).
